Not finding it? Sign in to also search OpenAlex live.
-
Improved assessment of coronary artery disease in obese patients with flurpiridaz-18F positron emission tomography myocardial perfusion imaging: A prespecified subgroup analysis of the AURORA phase 3 study
Krishna K. Patel, Jamshid Maddahi, Denis Agostini, Jeroen Joost Bax, Rob S. Beanlands, Daniel S. Berman, +9 more
2citations -
POSTER: MDS-1159: Long-Term Safety With Iptacopan Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria: Pooled Analysis of Data From Phase 2 and 3 Studies and the Roll-Over Extension Program2026 Clinical Lymphoma Myeloma & Leukemia article Immunology and Microbiology Complement system in diseases
Alexander Röth, Austin GKulasekararaj, Camilla Frieri, Flore Sicre de Fontbrune, Phillip Scheinberg, Bor‐Sheng Ko, +8 more
0citations -
POSTER: MPN-161: Benefit of Rusfertide Maintained in Patients With Low-Risk or High-Risk Polycythemia Vera: Efficacy and Safety Subgroup Analysis From the Randomized Controlled Phase 3 VERIFY Study2026 Clinical Lymphoma Myeloma & Leukemia article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment
Naveen Pemmaraju, Valentín García‐Gutiérrez, Aniket Bankar, Kristen Marie Pettit, Joseph Shatzel, Alessandro Lucchesi, +19 more
0citations -
POSTER: MPN-985: Effect of Rusfertide on Cytoreductive Therapy Use in Patients With Phlebotomy-Dependent Polycythemia Vera: Post Hoc Analysis From the Randomized Controlled Phase 3 VERIFY Study2026 Clinical Lymphoma Myeloma & Leukemia article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment
Andrew T Kuykendall, Francesca Palandri, Gregory Sumpao Vosganian, Aniket Bankar, Naveen Pemmaraju, Kristen Marie Pettit, +18 more
0citations -
COST-UTILITY ANALYSIS OF A MOLECULAR-INTEGRATED-PROFILE FOR WOMEN WITH (HIGH)INTERMEDIATE RISK ENDOMETRIAL CANCER - PORTEC-4A AN INTERNATIONAL, MULTICENTRE, RANDOMISED, PHASE 3 TRIAL2025 International Journal of Gynecological Cancer article Medicine Endometrial and Cervical Cancer Treatments
Anne Sophie V M van den Heerik, Nanda Horeweg, Marie A.D. Haverkort, Nienke Kuijsters, Stefan Kommoss, Friederike L.A. Koppe, +25 more
0citations -
ASO Visual Abstract: Health Care Utilization, Costs, and Cost-Effectiveness for Patients Undergoing Laparoscopic and Open Hemihepatectomy: A Secondary Analysis of the ORANGE II PLUS Randomised Controlled, Phase 3, Superiority Trial2026 Annals of Surgical Oncology article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life
Bram Olij, Gabriela Pilz da Cunha, Merel Kimman, Francesca Ratti, Mohammad Abu Hilal, Roberto Ivan Troisi, +29 more
0citations -
#3018 Iptacopan's rapid and sustained inhibition of overactive complement alternative pathway in C3G: Exploratory analysis from the Phase 3 APPEAR-C3G study2025 Nephrology Dialysis Transplantation article Immunology and Microbiology Complement system in diseases Open access
Erica Daina, Giuseppe Remuzzi, David Kavanagh, Imelda Schuhmann, Rubeen Israni, Hari Varun Kalluri, +4 more
0citations -
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study
Giorgio Gandaglia, Elio Mazzone, Armando Stabile, Antony Angelo Pellegrino, Vito Cucchiara, Francesco Maria Barletta, +12 more
98citations -
Updated Overall Survival Analysis From the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non–Small Cell Lung Cancer
Melissa Lynne Johnson, Egbert Frederik Smit, Enriqueta Felip, Suresh S. Ramalingam, Myung‐Ju Ahn, Anne S. Tsao, +14 more
16citations -
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial2022 Intestinal Research article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Toshifumi Hibi∥, Satoshi Motoya, Tadakazu Hisamatsu, Fumihito Hirai, Kenji Watanabe, Katsuyoshi Matsuoka, +10 more
15citations -
Exploratory Metabolomic Analysis Based on Reversed-Phase Liquid Chromatography–Mass Spectrometry to Study an In Vitro Model of Hypoxia-Induced Metabolic Alterations in HK-2 Cells2021 International Journal of Molecular Sciences article Biochemistry, Genetics and Molecular Biology Metabolomics and Mass Spectrometry Studies Open access
Samuel Bernardo‐Bermejo, Elena Sánchez‐López, Lei Tan, Selma Benito Martínez, Zhengjin Jiang, María Castro‐Puyana, +2 more
6citations -
Final analysis of the GMALL-PH-01 trial: phase II study of standard chemotherapy in combination with dasatinib in first line treatment of Philadelphia chromosome positive acute lymphoblastic leukemia2025 Leukemia & lymphoma/Leukemia and lymphoma article Medicine Acute Lymphoblastic Leukemia research Open access
Fabian Lang, Andreas Voß, Guido Kobbe, Christian Junghanß, Joachim Beck, Andreas Viardot, +10 more
1citations -
The density of tumour infiltrating lymphocytes in oesophago-gastric cancer varies with disease stage, geographical region and treatment: a post hoc analysis of nine phase III clinical trials
Georgina A. Keogh, Nina Šefčovičová, Tomio Arai, Myeong‐Cherl Kook, Jon P. Laye, William Allum, +26 more
0citations -
Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trials
Aaron Hudson, Scott A. Borgetti, Anne-Marie Rick, Matthew B. Laurens, Samuel T. Robinson, Cynthia L. Gay, +23 more
0citations -
Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL study
Marie José Kersten, Martin H. Dreyling, Kim Linton, Dana A. Chitu, Gerben J.C. Zwezerijnen, Sanne H. Tonino, +32 more
0citations -
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age2021 The Lancet Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access cited by 1 patent
Martine J Piccart, Laura van ‘t Veer, Coralie Poncet, Josephine Lopes Cardozo, Suzette Delaloge, Jean‐Yves Pierga, +26 more
376citations -
Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies
Philip J. Mease, Philip Helliwell, Dafna D. Gladman, Denis Poddubnyy, Xenofon Baraliakos, Soumya D. Chakravarty, +11 more
103citations -
Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial
Sabina Kersting, Julie M. N. Dubois, Kazem Nasserinejad, Johan A. Dobber, Clemens H. M. Mellink, Anne-Marie F. van der Kevie-Kersemaekers, +26 more
32citations